Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sho Fukui

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
International Journal of Rheumatic Diseases|December 19, 2025
Performance of Diagnostic Examinations for Giant Cell Arteritis and Subtypes: A Multicenter Japanese StudyNobuhiro Oda, Sho Fukui, Fumika N Nagase, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 14, 2024
Weight Reduction and Target Serum Urate Level: A Longitudinal Study of Annual Medical ExaminationSho Fukui, Masato Okada, Tomohiro Shinozaki, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 3, 2025
Longitudinal Changes in Serum Urate Levels from Pre-menopause through Post-menopause: Interrupted Time-Series AnalysesShreya Billa, Sho Fukui, Misti L Paudel, et al.
The Journal of Rheumatology|November 15, 2024
Tocilizumab (TCZ) for Giant Cell Arteritis: Clinical Outcomes Following Relapses and TCZ Discontinuation Due to Adverse EventsFumika N Nagase, Sho Fukui, Naoho Takizawa, et al.
The Lancet. Rheumatology|April 25, 2026
Effectiveness and persistence of biological and targeted synthetic treatment in patients with rheumatoid arthritis and chronic kidney disease: a multicentre, prospective cohort studySho Fukui, Hilde S Ørbo, Sara K Tedeschi, et al.
The American Journal of Hospice & Palliative Care|December 8, 2025
Association Between Patient-Reported Engagement and Medical Record of Advance Care Planning Among Older Adults in the ED: A Cross Sectional StudyNanako Shirai, Tadayuki Hashimoto, Sho Fukui, et al.
Seminars in Arthritis and Rheumatism|April 28, 2025
Development of a prediction model for progression of rheumatoid arthritis-associated interstitial lung disease using serologic and clinical factors: The prospective KORAIL cohortSung Hae Chang, Misti L Paudel, Gregory C McDermott, et al.
Rheumatology International|May 9, 2022
Clinical characteristics of patients with spondyloarthritis and inflammatory bowel disease versus inflammatory bowel disease-related arthritisKeisuke Ono, Mitsumasa Kishimoto, Gautam A Deshpande, et al.
RMD Open|September 17, 2021
Clinical characteristics of non-radiographic versus radiographic axial spondyloarthritis in Asia and non-radiographic axial spondyloarthritis in other regions: results of the cross-sectional ASAS-COMOSPA studyMitsumasa Kishimoto, Keisuke Ono, Sho Fukui, et al.
Modern Rheumatology|May 30, 2024
Systematic review and meta-analysis for the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritisYoichi Nakayama, Wataru Nagata, Yoichi Takeuchi, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
International Journal of Rheumatic Diseases|December 19, 2025
Performance of Diagnostic Examinations for Giant Cell Arteritis and Subtypes: A Multicenter Japanese StudyNobuhiro Oda, Sho Fukui, Fumika N Nagase, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 14, 2024
Weight Reduction and Target Serum Urate Level: A Longitudinal Study of Annual Medical ExaminationSho Fukui, Masato Okada, Tomohiro Shinozaki, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 3, 2025
Longitudinal Changes in Serum Urate Levels from Pre-menopause through Post-menopause: Interrupted Time-Series AnalysesShreya Billa, Sho Fukui, Misti L Paudel, et al.
The Journal of Rheumatology|November 15, 2024
Tocilizumab (TCZ) for Giant Cell Arteritis: Clinical Outcomes Following Relapses and TCZ Discontinuation Due to Adverse EventsFumika N Nagase, Sho Fukui, Naoho Takizawa, et al.
The Lancet. Rheumatology|April 25, 2026
Effectiveness and persistence of biological and targeted synthetic treatment in patients with rheumatoid arthritis and chronic kidney disease: a multicentre, prospective cohort studySho Fukui, Hilde S Ørbo, Sara K Tedeschi, et al.
The American Journal of Hospice & Palliative Care|December 8, 2025
Association Between Patient-Reported Engagement and Medical Record of Advance Care Planning Among Older Adults in the ED: A Cross Sectional StudyNanako Shirai, Tadayuki Hashimoto, Sho Fukui, et al.
Seminars in Arthritis and Rheumatism|April 28, 2025
Development of a prediction model for progression of rheumatoid arthritis-associated interstitial lung disease using serologic and clinical factors: The prospective KORAIL cohortSung Hae Chang, Misti L Paudel, Gregory C McDermott, et al.
Rheumatology International|May 9, 2022
Clinical characteristics of patients with spondyloarthritis and inflammatory bowel disease versus inflammatory bowel disease-related arthritisKeisuke Ono, Mitsumasa Kishimoto, Gautam A Deshpande, et al.
RMD Open|September 17, 2021
Clinical characteristics of non-radiographic versus radiographic axial spondyloarthritis in Asia and non-radiographic axial spondyloarthritis in other regions: results of the cross-sectional ASAS-COMOSPA studyMitsumasa Kishimoto, Keisuke Ono, Sho Fukui, et al.
Modern Rheumatology|May 30, 2024
Systematic review and meta-analysis for the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritisYoichi Nakayama, Wataru Nagata, Yoichi Takeuchi, et al.
Pageof 11